Media Release September 2, 2020 Medacta Receives FDA Clearance for the Lateralized Glenosphere Read More > Ad-hoc Release July 22, 2020 Medacta Half-year 2020 revenue equal to Euro 135M, down 11.1% over the prior year due to COVID-19 related deferrals of orthopedic elective surgeries. Go...
To potentially further improve KA results and ultimately patient satisfaction, Medacta has developed GMK SpheriKA, the first KA-optimized implant. GMK SpheriKA was developed starting from the strong heritage of GMK Sphere, with a particular focus on the anterior aspect of the femur....
Media Release September 2, 2020 Medacta Receives FDA Clearance for the Lateralized Glenosphere Read More > Ad-hoc Release July 22, 2020 Medacta Half-year 2020 revenue equal to Euro 135M, down 11.1% over the prior year due to COVID-19 related deferrals of orthopedic elective surgeries. Go...
NewsNovember 5, 2021Medacta marks its GMK Sphere 10-year anniversary Read more > Media ReleaseOctober 19, 2021Medacta extends the personalized medicine concept to total knee revision surgeries with the unique and innovative MyKnee R patient-specific solution ...